Most therapeutic peptides used in longevity and performance medicine are sourced from compounding pharmacies rather than traditional pharmaceutical manufacturers. Compounding pharmacy pricing is not standardized across providers — the same peptide at the same dosage can cost meaningfully different amounts depending on the pharmacy relationship, the clinic overhead, and whether the cost is bundled into a broader membership.

The consultations and monitoring that accompany responsible peptide use also add to the real cost. A clinic that shows a very low per-vial price may still have a higher total cost once initial consultation fees, required lab work, and follow-up visits are accounted for.

BPC-157 is one of the most widely used peptides for recovery and tissue repair. Compounded BPC-157 typically ranges from $50 to $150 per vial depending on dosage and sourcing, with monthly protocols often running $100 to $300 all-in through physician-supervised programs.

Ipamorelin and CJC-1295 are frequently prescribed together to support growth hormone release. Combined protocols typically run $150 to $400 per month depending on dosage and provider. Growth hormone secretagogues like these are among the more popular protocols at full-spectrum longevity platforms.

GLP-1 agonists such as semaglutide and tirzepatide have become among the most discussed compounds in this space. Compounded semaglutide programs range widely — from $150 to $500 per month — depending on dosage, the compounding pharmacy used, and whether clinical oversight is bundled.

The most useful comparison looks at total monthly cost rather than per-vial or per-dose numbers. Total monthly cost includes the peptide itself, any required consultation or follow-up fees, lab work expected by the clinic, and shipping if the medication is mailed.

Bundled platforms — telehealth longevity memberships that include peptides as part of a broader protocol — often become more cost-effective at higher service volumes. If you are already paying for a membership that covers hormone optimization and diagnostics, adding a peptide protocol within the same platform is usually more efficient than sourcing it from a separate provider.

Peptides marketed online without any clinical oversight or prescription model are operating in a different category than physician-prescribed compounding pharmacy protocols. The regulatory landscape for compounded peptides has evolved, and sourcing from unregulated channels carries meaningful quality and safety risk.

Very low prices without an associated consultation model are a signal worth investigating. Responsible peptide therapy requires baseline labs, physician oversight, and protocol adjustments — if none of those are mentioned, the cheaper option may not be offering comparable clinical value.